Understanding the Regulatory Terminology of Potential Preventions and Treatments for COVID-19

https://www.fda.gov/emergency-preparedness-and-response/about-mcmi/mcmi-newsletters?utm_campaign=6%2F3%20MCMi%20Coronavirus%20update&utm_medium=email&utm_source=Eloqua&elqTrackId=FBBEE675DA0C17EF64ACFD994F9ED015&elq=481bb387abf84189866cd29f4796a52d&elqaid=12807&elqat=1&elqCampaignId=10903

Understanding the Regulatory Terminology of Potential Preventions and Treatments for COVID-19

There’s a lot of confusion about which medical products might work to prevent or treat coronavirus disease 2019 (COVID-19). Scientists are working hard to develop a number of potential drugs for the prevention or treatment of coronavirus, but none are currently approved by the FDA for these purposes.

The language used to describe potential therapies can be confusing, and there’s public interest around the FDA’s work to ensure access to potentially life-saving treatments. Here’s what those terms mean.

Find additional coronavirus disease 2019 (COVID-19) updates on our website and in the Medical Countermeasures Initiative newsletter.